Merrimack Pharmaceuticals (NASDAQ:MACK) Cut to Sell at StockNews.com

StockNews.com downgraded shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) from a hold rating to a sell rating in a research report sent to investors on Friday morning. Merrimack Pharmaceuticals Stock Performance Shares of MACK opened at $12.19 on Friday. The business has a 50-day moving average of $12.51 and a 200 day moving average […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Massachusetts ,United States , ,Merrimack Pharmaceuticals Stock Performance ,Boothbay Fund Management ,News Ratings For Merrimack Pharmaceuticals Daily ,Merrimack Pharmaceuticals ,Merrimack Pharmaceuticals Inc ,Institutional Investors Weigh In On Merrimack Pharmaceuticals ,Merrimack Pharmaceuticals Company Profile ,Get Rating ,Avenue Partners ,Fund Management ,Jane Street Group ,Merrimack Pharmaceuticals Daily ,